# Kazia Therapeutics Ltd: Form 6-K, filed Dec 11, 2024

- Company: [Kazia Therapeutics Ltd](/companies/kzia.md) (CIK 1075880)
- Form: 6-K
- Filed: 2024-12-11
- Accepted by EDGAR: Dec 11, 2024, 08:58 ET
- Period: 2024-12-11
- Accession: 0001193125-24-274916
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1075880/000119312524274916/d904031d6k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1075880/000119312524274916/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1075880/000119312524274916/d904031d6k.htm

Filed Dec 11, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-274916. Last ingested by Listed: Nov 2, 2026, 16:21 ET. No prices; not investment advice.
